Similar articles for PMID: 31106607

Year	Number of Results
2007	4
2008	2
2009	2
2010	5
2011	4
2012	7
2013	7
2014	11
2015	18
2016	18
2017	17
2018	27
2019	41
2020	50
2021	45
2022	54
2023	18
2024	0

1

Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.

Emond B, Ellis LA, Chakravarty SD, Ladouceur M, Lefebvre P. Emond B, et al. Curr Med Res Opin. 2019 Oct;35(10):1751-1759. doi: 10.1080/03007995.2019.1620713. Epub 2019 Jun 6. Curr Med Res Opin. 2019. PMID: 31106607

2

Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.

Penso L, Bergqvist C, Meyer A, Herlemont P, Weill A, Zureik M, Dray-Spira R, Sbidian E. Penso L, et al. Arthritis Rheumatol. 2022 Feb;74(2):244-252. doi: 10.1002/art.41923. Arthritis Rheumatol. 2022. PMID: 34279061

3

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.

Burisch J, Eigner W, Schreiber S, Aletaha D, Weninger W, Trauner M, Reinisch W, Narula N. Burisch J, et al. PLoS One. 2020 May 27;15(5):e0233781. doi: 10.1371/journal.pone.0233781. eCollection 2020. PLoS One. 2020. PMID: 32459816 Free PMC article.

4

Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.

Lyu R, Govoni M, Ding Q, Black CM, Kachroo S, Fan T, Ogbonnaya A, Donga P, Hill J, Makin C. Lyu R, et al. Rheumatol Int. 2016 Jan;36(1):143-53. doi: 10.1007/s00296-015-3348-4. Epub 2015 Aug 28. Rheumatol Int. 2016. PMID: 26314368

5

Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.

Hudesman DP, Chakravarty SD, Emond B, Ellis LA, Lefebvre P, Sadik K, Scher JU. Hudesman DP, et al. BMC Rheumatol. 2020 Apr 2;4:16. doi: 10.1186/s41927-020-0115-2. eCollection 2020. BMC Rheumatol. 2020. PMID: 32266326 Free PMC article.

6

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.

Toussirot É, Houvenagel É, Goëb V, Fouache D, Martin A, Le Dantec P, Dernis E, Wendling D, Ansemant T, Berthelot JM, Bader-Meunier B, Kantelip B; Le CRI. Toussirot É, et al. Joint Bone Spine. 2012 Oct;79(5):457-63. doi: 10.1016/j.jbspin.2011.10.001. Epub 2011 Nov 15. Joint Bone Spine. 2012. PMID: 22088934

7

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.

Zhang J, Sridhar G, Barr CE, Eichelberger B, Lockhart CM, Marshall J, Clewell J, Accortt NA, Curtis JR, Holmes C, McMahill-Walraven CN, Brown JS, Haynes K. Zhang J, et al. J Manag Care Spec Pharm. 2020 Apr;26(4):417-490. doi: 10.18553/jmcp.2020.26.4.417. J Manag Care Spec Pharm. 2020. PMID: 32223608 Free PMC article.

8

Real-world risk of new-onset inflammatory bowel disease among patients with psoriasis exposed to interleukin 17 inhibitors.

Wright S, Alloo A, Strunk A, Garg A. Wright S, et al. J Am Acad Dermatol. 2020 Aug;83(2):382-387. doi: 10.1016/j.jaad.2020.04.010. Epub 2020 Apr 11. J Am Acad Dermatol. 2020. PMID: 32289401

9

Real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications among patients with psoriatic arthritis treated with IL-17A inhibitors in the United States.

Pizzicato LN, Vadhariya A, Birt J, Ketkar AG, Bolce R, Grabner M, Pepe RS, Walsh JA. Pizzicato LN, et al. J Manag Care Spec Pharm. 2023 Jan;29(1):24-35. doi: 10.18553/jmcp.2022.22144. Epub 2022 Nov 1. J Manag Care Spec Pharm. 2023. PMID: 36318701 Free PMC article.

10

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.

Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T. Schreiber S, et al. Ann Rheum Dis. 2019 Apr;78(4):473-479. doi: 10.1136/annrheumdis-2018-214273. Epub 2019 Jan 23. Ann Rheum Dis. 2019. PMID: 30674475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

280 results

Results by year